SN 10 Health & Medicine

Isaac Kinde: Finding cancer via altered genes

Baltimore biotech star aims to detect cancer mutations early

Isaac Kinde headshot

DETECTION  Isaac Kinde, 31, is the chief scientific officer of PapGene, Inc. The company’s technologies can identify mutations commonly associated with cancer. 

Courtesy of I. Kinde

By Sarah Schwartz

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

  1. the libido-boosting drug Addyi
    Health & Medicine

    50 years ago, an experimental drug hinted at serotonin’s many roles in the brain

    By Lisa Grossman
  2. COVID-19 patient in the ICU
    Health & Medicine

    Defects in early immune responses underlie some severe COVID-19 cases

    By Erin Garcia de Jesus
  3. photograph of China’s Chang'e-4 lunar lander on the moon
    Space

    A new moon radiation measurement may help determine health risks to astronauts

    By Aayushi Pratap
  4. nerve cells and a tiny robot
    Neuroscience

    Tiny, magnetically controlled robots coax nerve cells to grow connections

    By Laura Sanders
  5. Manaus cemetary
    Health & Medicine

    A Brazilian city devastated by COVID-19 may have reached herd immunity

    By Jonathan Lambert
  6. man putting mask on youth
    Health & Medicine

    Early immune responses may be why younger people get less sick from COVID-19

    By Erin Garcia de Jesus
  7. monoclonal antibodies illustration
    Health & Medicine

    Antibodies made in the lab show some promise for treating COVID-19

    By Erin Garcia de Jesus
  8. SARS-Cov-2, the virus that causes COVID-19 (left) and influenza (H1N1 shown in green)
    Health & Medicine

    What will happen when COVID-19 and the flu collide this fall?

    By Tina Hesman Saey

From the Nature Index

Paid Content